V-2 Nov 95

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mother‐to‐infant transmission of hepatitis C virus

  2001cited by this paper
• Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus

  1995cited by this paper
• Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group.

  1995cited by this paper
• Development of Lymphoid Hyperplasia in Transgenic Mice Expressing the HIV tat Gene

  1995cited by this paper
• Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR.

  1995cited by this paper
• The development of PCR based assays for the detection and differentiation of simian immunodeficiency virus in vivo.

  1995cited by this paper
• Suppression of Human Immunodeficiency Virus Type 1 Activity in Vitro by Oligonucleotides Which Form Intramolecular Tetrads (*)

  1995cited by this paper
• HIV-1 and HHV-6 antigens and transcripts in retinas of patients with AIDS in the absence of human cytomegalovirus.

  1995cited by this paper
• A homologue of the human MSS1 gene, a positive modulator of HIV-1 gene expression, is massively expressed in Xenopus oocytes.

  1995cited by this paper
• Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein

  1995cited by this paper
• Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes

  1995cited by this paper
• Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors.

  1995cited by this paper
• Solution structure of a homopyrimidine: homopurine dodecamer encoded by the HIV-1 envelope gene: NMR and molecular simulation studies.

  1995cited by this paper
• Molecular analysis of clonality in Castleman's disease.

  1995cited by this paper
• Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants

  1995cited by this paper
• In vivo stability and disposition of a self-stabilized oligodeoxynucleotide phosphorothioate in rats.

  1995cited by this paper
• Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis.

  1995cited by this paper
• An experimental chemically inactivated HIV-1 vaccine induces antibodies that neutralize homologous and heterologous viruses.

  1995cited by this paper
• Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand

  1995cited by this paper
• CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1.

  1995cited by this paper
• Siamycins I and II, new anti-HIV peptides: I. Fermentation, isolation, biological activity and initial characterization.

  1995cited by this paper
• Retinoic acid inhibition of ex vivo human immunodeficiency virus-associated apoptosis of peripheral blood cells.

  1995cited by this paper
• Cloning of an SNF2/SWI2-related Protein That Binds Specifically to the SPH Motifs of the SV40 Enhancer and to the HIV-1 Promoter (*)

  1995cited by this paper
• Identification of an idiotypic peptide recognized by autoantibodies in human immunodeficiency virus-1-infected individuals.

  1995cited by this paper
• Protein structure-based design of potent orally bioavailable, nonpeptide inhibitors of human immunodeficiency virus protease.

  1995cited by this paper
• Real-time analysis of the transcriptional regulation of HIV and hCMV promoters in single mammalian cells.

  1995cited by this paper
• Adherence of human immunodeficiency virus-infected lymphocytes to fetal placental cells: a model of maternal --> fetal transmission.

  1995cited by this paper
• NMR mapping of the antigenic determinant recognized by an anti-gp120, human immunodeficiency virus neutralizing antibody.

  1995cited by this paper
• Interaction of several complement proteins with gp120 and gp41, the two envelope gycoproteins of HIV‐1

  1995cited by this paper
• Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates

  1995cited by this paper
• Systemic production of foreign peptides on the particle surface of tobacco mosaic virus

  1995cited by this paper
• Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain

  1995cited by this paper
• Secondary structure in solution of two anti‐HIV‐1 hammerhead ribozymes as investigated by two‐dimensional 1H 500 MHz NMR spectroscopy in water

  1995cited by this paper
• Characterization of the internal motions of Escherichia coli ribonuclease HI by a combination of 15N-NMR relaxation analysis and molecular dynamics simulation: examination of dynamic models.

  1995cited by this paper
• [Functions of human immunodeficiency virus regulatory genes].

  1995cited by this paper
• Requirement for HIV-1 TAR sequences for Tat activation in rodent cells.

  1995cited by this paper
• [Apoptosis or programmed cell death: regulatory and pathophysiological mechanisms].

  1995cited by this paper
• Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat.

  1995cited by this paper
• Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx

  1995cited by this paper
• Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

  1995cited by this paper
• Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding

  1995cited by this paper
• Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity.

  1995cited by this paper
• Competitive inhibition of HIV-1 protease by biphenyl carboxylic acids.

  1995cited by this paper
• Effect of Adjuvants on Immunogenicity of MN Recombinant Glycoprotein 120 in Guinea Pigs

  1995cited by this paper
• Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy

  1995cited by this paper
• Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro.

  1995cited by this paper
• Neither whole inactivated virus immunogen nor passive immunoglobulin transfer protects against SIVagm infection in the African green monkey natural host.

  1995cited by this paper
• Comparison of HIV-1 protease expression in different fusion forms.

  1995cited by this paper
• An expanded model of replicating human immunodeficiency virus reverse transcriptase.

  1995cited by this paper
• Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1.

  1995cited by this paper
• Induction of resistance to 1-beta-D-arabinofuranosylcytosine in human H9 cell line by simian immunodeficiency virus.

  1995cited by this paper
• Characterisation of foscarnet-resistant strains of human immunodeficiency virus type 1.

  1995cited by this paper
• Two Partially Overlapping Antiviral Peptides from the External Portion of HIV Type 1 Glycoprotein 41, Adjoining the Transmembrane Region, Affect the Glycoprotein 41 Fusion Domain

  1995cited by this paper
• Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat.

  1995cited by this paper
• Repression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat

  1995cited by this paper
• The proteins of lymphocyte- and macrophage-tropic strains of simian immunodeficiency virus are processed differently in macrophages.

  1995cited by this paper
• Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes

  1995cited by this paper
• Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV‐infected subjects

  1995cited by this paper
• Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.

  1995cited by this paper
• Design and synthesis of nonpeptide peptidomimetic inhibitors of renin

  1995cited by this paper
• NMR solution structure of the RNA-binding peptide from human immunodeficiency virus (type 1) Rev.

  1995cited by this paper
• Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden.

  1995cited by this paper
• Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys.

  1995cited by this paper
• Design of B‐DNA cross‐linking and sequence‐reading molecules

  1995cited by this paper

• No citing papers are available for this paper.